Paul A. Mahon serves as Executive at UNITED THERAPEUTICS CORP, where they oversee executive responsibilities. Since joining the company, Paul A. Mahon has executed 1088 insider transactions totaling $226.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 10, 2025 involved selling 1,358 shares valued at $409.0K.
Paul A. Mahon currently holds 36,781 shares of UNITED THERAPEUTICS CORP (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul A. Mahon has been a net seller of UTHR stock. They have purchased $0 and sold $226.1M worth of shares.
Paul A. Mahon's most recent insider trade was on Jul 10, 2025, when they sold 1,358 shares at $301.20 per share.
Get notified when new Form 4 filings are submitted
| $297.89 |
| Discretionary |
| Jul 10, 2025 | UTHR | $1.5M | Option Exercise | 11,000 | $135.42 | Discretionary |
| Sep 19, 2024 | UTHR | $2.7M | Disposition | 7,700 | $351.33 | Planned |
| Sep 19, 2024 | UTHR | $1.3M | Option Exercise | 7,700 | $163.30 | Planned |
| Jun 20, 2024 | UTHR | $4.1M | Option Exercise | 25,000 | $163.30 | Discretionary |
| Jun 20, 2024 | UTHR | $7.7M | Disposition | 25,000 | $308.98 | Discretionary |
| Apr 4, 2024 | UTHR | $48.2K | Sale | 206 | $234.09 | Planned |
| Apr 4, 2024 | UTHR | $706.6K | Option Exercise | 6,000 | $117.76 | Planned |
| Apr 4, 2024 | UTHR | $22.9K | Sale | 100 | $228.84 | Planned |
| Apr 4, 2024 | UTHR | $317.4K | Sale | 1,374 | $230.99 | Planned |
| Apr 4, 2024 | UTHR | $243.2K | Sale | 1,041 | $233.64 | Planned |
| Apr 4, 2024 | UTHR | $762.5K | Sale | 3,279 | $232.55 | Planned |
| Mar 21, 2024 | UTHR | $56.1K | Sale | 238 | $235.73 | Planned |
| Mar 21, 2024 | UTHR | $200.6K | Sale | 857 | $234.11 | Planned |
| Mar 21, 2024 | UTHR | $706.6K | Option Exercise | 6,000 | $117.76 | Planned |
| Mar 21, 2024 | UTHR | $829.7K | Sale | 3,505 | $236.71 | Planned |
| Mar 21, 2024 | UTHR | $332.3K | Sale | 1,400 | $237.36 | Planned |
| Mar 7, 2024 | UTHR | $642.0K | Sale | 2,700 | $237.76 | Planned |
| Mar 7, 2024 | UTHR | $706.6K | Option Exercise | 6,000 | $117.76 | Planned |
| Mar 7, 2024 | UTHR | $710.7K | Sale | 3,000 | $236.90 | Planned |
| Mar 7, 2024 | UTHR | $71.7K | Sale | 300 | $238.85 | Planned |
| Feb 15, 2024 | UTHR | $332.5K | Sale | 1,550 | $214.54 | Planned |
| Feb 15, 2024 | UTHR | $706.6K | Option Exercise | 6,000 | $117.76 | Planned |
| Feb 15, 2024 | UTHR | $724.3K | Sale | 3,362 | $215.43 | Planned |
| Feb 15, 2024 | UTHR | $235.1K | Sale | 1,088 | $216.04 | Planned |
| Feb 1, 2024 | UTHR | $86.5K | Sale | 400 | $216.37 | Planned |
| Feb 1, 2024 | UTHR | $706.6K | Option Exercise | 6,000 | $117.76 | Planned |
| Feb 1, 2024 | UTHR | $256.3K | Sale | 1,200 | $213.58 | Planned |
| Feb 1, 2024 | UTHR | $343.5K | Sale | 1,601 | $214.53 | Planned |